Clinical trials: Active File EXOMA2 Study
All Types of Metastatic Solid Malignancy, 1st-line Treatment
Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.
Currently, the EXOMA2 study (NCT04614480) offers earlier and more comprehensive exome analysis in the management of cancer patients than EXOMA.
- Conditions
- All Types of Metastatic Solid Malignancy, 1st-line Treatment, Exome Analysis, Active File EXOMA2 Study
- Trial name
- INFOGENE (NCT06550687)
- Testing
- Cancer patients' preferences regarding genetic information modalities prior to theranostic exome analysis
- Where
- 2 sites in France
- Volunteers
- 80 people
- Sponsor
- Centre Georges Francois Leclerc